Authors
Heuschkel, J., Kingsley, L., Reed, J., Li, D., Warner, M., Pefaur, N., Cramer, S.
Abstract
Directed evolution is commonly used in protein engineering, where mature molecules are routinely improved through iterative local search of amino acid space. Here, we extend this principle to coding DNA. We developed a language-model-guided framework that iteratively refined industry-optimized coding sequences of clinical-stage therapeutics through synonymous exploration of codon space. Across 24 antibody-based therapeutics, SynCodonLM-guided refinement significantly increased recombinant expression in CHO cells for 18 molecules (75% responder rate), without detectable compromise of product-quality or biophysical attributes. Moreover, changes in model likelihood predicted expression gains more effectively than heuristic statistical or mRNA-structure descriptors, despite no explicit expression objective. Codon-level likelihood also tracked temporal progression in influenza A H1N1 sequences, indicating the model captures evolutionary signal. These results show that even production-optimized sequences retain accessible fitness in synonymous codon space, establishing directed evolution as a practical strategy to improve biologic expression, a key manufacturing bottleneck, without altering protein sequence.
Preprint server:
bioRxiv
The authors list and abstract were imported from bioRxiv on 05 Aug 2026.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 32
- Comments 0